LymphaCare Expands by Offering RevitaMed Therapy, a Pain Relieving Therapeutic Device for House Infrared Therapy Treating Diabetic Neuropathy, Chronic Discomfort, and Lymphedema

New York, NY (PRWEB) December 18, 2004

RevitaMed and LymphaCare are attempting to assist patients with lymphedema, vascular illness, and diabetic neuropathy see the light, or rather infrared light therapy. http://www.infraredtherapy.com

Diabetic neuropathy is a lack of capability to feel vibrations, for example from a tuning fork. This test can be carried out in the course of your normal checkup for diabetes. The exact same sort of nerve harm can happen in the hands. This is uncommon, and is always accompanied by problems in the feet and legs. Regrettably, this sort of nerve harm is permanent. Once it’s happened, it isn’t improved by much better control of diabetes.

By carrying the RevitaMed, LymphaCare will be able to offer its buyers a superior Infrared Therapy device at a low cost they desire. As far more patients and facilities look for additional anodyne, or something that gives discomfort relief therapy, LymphaCare will be able to meet those requirements. Offering a far more successful and considerably less expensive alternative to far more widely recognized Anodyne® Therapy (http://www.anodynetherapy.com) as part of its product line by carrying the FDA approved RevitaMed system for Infrared Therapy.

LymphaCare is already nationally recognized as a leader in supplying patients and clinics with residence compression therapy products for lymphedema and venous insufficiency. They are experts in insurance reimbursement and coverage of lymphedema goods which are accessible in all 50 states and internationally. http://www.lymphcare.com

Lymphedema is the chronic swelling or feeling of tightness in the arm or hand due to an accumulation of lymphatic fluid in the soft tissue of the arm. The condition occurs when lymph vessels, which generally carry excess fluid out of the limbs and back into central circulation, have had their flow interrupted. Axillary (underarm) lymph node removal is generally performed on breast cancer patients to stage or treat their cancer. However, between 15% and 20% of breast cancer patients who undergo axillary lymph node removal develop lymphedema. According to the American Cancer Society, of the two million breast cancer survivors in the U.S., approximately 400,000 need to cope with lymphedema on a daily basis. (http://www.lymphnet.org)

LymphaCare can be reached at 800-288-1801.

# # #

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

gead2.googlesyndication.com/pagead/show_ads.js">